147 related articles for article (PubMed ID: 25997612)
1. Role of hypoxia-inducible factor-1α and CD146 in epidermal growth factor receptor-mediated angiogenesis in salivary gland adenoid cystic carcinoma.
Wang WM; Zhao ZL; Zhang WF; Zhao YF; Zhang L; Sun ZJ
Mol Med Rep; 2015 Sep; 12(3):3432-3438. PubMed ID: 25997612
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of hypoxia‑inducible factor-1α inhibits growth, invasion, and angiogenesis of human salivary adenoid cystic carcinoma cells under hypoxia.
Xiao C; Pan Y; Zeng X; Wang L; Li Z; Yan S; Wang H
Oncol Rep; 2018 Sep; 40(3):1675-1683. PubMed ID: 30015895
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of survivin reduces HIF-1α, TGF-β1 and TFE3 in salivary adenoid cystic carcinoma.
Wang YF; Ma SR; Wang WM; Huang CF; Zhao ZL; Liu B; Zhang WF; Zhao YF; Zhang L; Sun ZJ
PLoS One; 2014; 9(12):e114051. PubMed ID: 25485635
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin.
Vered M; Braunstein E; Buchner A
Head Neck; 2002 Jul; 24(7):632-6. PubMed ID: 12112535
[TBL] [Abstract][Full Text] [Related]
5. [Expression of epidermal growth factor receptor in salivary adenoid cystic carcinoma and its role in cancer invasion].
Ge MH; Ling ZQ; Tan Z; Chen C; Xu JJ; Yu JL
Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):278-80. PubMed ID: 22781040
[TBL] [Abstract][Full Text] [Related]
6. Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome.
Zhang J; Peng B; Chen X
Clin Cancer Res; 2005 Oct; 11(20):7334-43. PubMed ID: 16243805
[TBL] [Abstract][Full Text] [Related]
7. In vitro angiogenesis and expression of nuclear factor kappaB and VEGF in high and low metastasis cell lines of salivary gland Adenoid Cystic Carcinoma.
Zhang J; Peng B
BMC Cancer; 2007 Jun; 7():95. PubMed ID: 17543095
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mTOR reduce Stat3 and PAI related angiogenesis in salivary gland adenoid cystic carcinoma.
Yu GT; Bu LL; Zhao YY; Liu B; Zhang WF; Zhao YF; Zhang L; Sun ZJ
Am J Cancer Res; 2014; 4(6):764-75. PubMed ID: 25520866
[TBL] [Abstract][Full Text] [Related]
9. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.
Gibbons MD; Manne U; Carroll WR; Peters GE; Weiss HL; Grizzle WE
Laryngoscope; 2001 Aug; 111(8):1373-8. PubMed ID: 11568571
[TBL] [Abstract][Full Text] [Related]
10. Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: correlation with tumor progression and patients' prognosis.
Yang X; Dai J; Li T; Zhang P; Ma Q; Li Y; Zhou J; Lei D
Oral Oncol; 2010 Oct; 46(10):755-60. PubMed ID: 20850374
[TBL] [Abstract][Full Text] [Related]
11. Expression and significance of notch signaling pathway in salivary adenoid cystic carcinoma.
Bell D; Hanna EY; Miele L; Roberts D; Weber RS; El-Naggar AK
Ann Diagn Pathol; 2014 Feb; 18(1):10-3. PubMed ID: 24238845
[TBL] [Abstract][Full Text] [Related]
12. Characterization and localization of c-kit and epidermal growth factor receptor in different patterns of adenoid cystic carcinoma.
Jain A; Shetty DC; Rathore AS; Kumar K
J Cancer Res Ther; 2016; 12(2):834-9. PubMed ID: 27461660
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of vascular endothelial growth factor in high- and low-metastasis cell lines of salivary gland adenoid cystic carcinoma.
Kondo S; Mukudai Y; Soga D; Nishida T; Takigawa M; Shirota T
Anticancer Res; 2014 Feb; 34(2):671-7. PubMed ID: 24510998
[TBL] [Abstract][Full Text] [Related]
14. Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.
Beppu S; Ito Y; Fujii K; Saida K; Takino H; Masaki A; Murase T; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Ijichi K; Murakami S; Inagaki H
Histopathology; 2017 Aug; 71(2):305-315. PubMed ID: 28370175
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
Monteiro LS; Bento MJ; Palmeira C; Lopes C
J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1α and Notch1 in head neck squamous cell carcinoma.
Wang WM; Zhao ZL; Ma SR; Yu GT; Liu B; Zhang L; Zhang WF; Kulkarni AB; Sun ZJ; Zhao YF
PLoS One; 2015; 10(2):e0119723. PubMed ID: 25723392
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas.
Schneider T; Strehl A; Linz C; Brands R; Hartmann S; Beckford F; Rosenwald A; Kübler AC; Müller-Richter UD
Clin Oral Investig; 2016 Apr; 20(3):541-51. PubMed ID: 26245271
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of LAG3, TIM3, and A2aR in adenoid cystic carcinoma and mucoepidermoid carcinoma.
Zhang MJ; Wu CC; Wang S; Yang LL; Sun ZJ
Oral Dis; 2023 Jan; 29(1):175-187. PubMed ID: 34651389
[TBL] [Abstract][Full Text] [Related]
19. Bmi-1 expression predicts prognosis in salivary adenoid cystic carcinoma and correlates with epithelial-mesenchymal transition-related factors.
Yi C; Li BB; Zhou CX
Ann Diagn Pathol; 2016 Jun; 22():38-44. PubMed ID: 27180058
[TBL] [Abstract][Full Text] [Related]
20. AGR2 promotes the proliferation, migration and regulates epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
Ma SR; Mao L; Deng WW; Li YC; Bu LL; Yu GT; Zhang WF; Sun ZJ
Am J Transl Res; 2017; 9(2):507-519. PubMed ID: 28337279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
